UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028567
Receipt number R000032686
Scientific Title Prospective study to evaluate the clinical outcome of POEM combined with endoscopic anti-reflux surgery.
Date of disclosure of the study information 2017/08/08
Last modified on 2020/08/18 12:26:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study to evaluate the clinical outcome of POEM combined with endoscopic anti-reflux surgery.

Acronym

Endoscopic anti-reflux surgery and POEM

Scientific Title

Prospective study to evaluate the clinical outcome of POEM combined with endoscopic anti-reflux surgery.

Scientific Title:Acronym

Endoscopic anti-reflux surgery and POEM

Region

Japan


Condition

Condition

esophageal achalasia

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical outcome and safety of POEM combined with endoscopic anti-reflux surgery.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1: The reslut of multichannel intraluminal impedance pH monitoring(MII-pH)
2: endoscopic findings
3: symptoms
4: whether the patients needs PPI or not
in 2 months later and 1 year later from the surgery.
5: QERD-Q score and F-scale

Key secondary outcomes

1: The clinical outcome of POEM(Eckardt score, esophageal manometry, esophagography)
2: Adverse event due to surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

conventional POEM

Interventions/Control_2

adding endoscopic anti-reflux surgery

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who are planning to undergo POEM surgery, and who can recieve informed consent document.

Key exclusion criteria

1: severe achalasia (ex. sigmoid type)
2: non-achalasia
3: taking anti-thrombotic agents
4: who has severe complications(Diabetes, Heart disease, Strokes, Neurological disorder,
Psychosis, etc.)
5: a history of complications with anesthesia
6: pregnant and breast-feeding
7: who cannot withdraw PPI
8: consent can not be obtained
9: other inappropriate cases

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Haruhiro
Middle name
Last name Inoue

Organization

Showa University Koto Toyosu Hospital

Division name

Digestive Disease Center

Zip code

1358577

Address

5-1-38 Toyosu Koto-ku, Tokyo, Japan

TEL

03-6204-6000

Email

haru.inoue@med.showa-u.ac.jp


Public contact

Name of contact person

1st name Akiko
Middle name
Last name Toshimori

Organization

Showa University Koto Toyosu Hospital

Division name

Digestive disease center

Zip code

1358577

Address

5-1-38 Toyosu Koto-ku, Tokyo, Japan

TEL

03-6204-6000

Homepage URL


Email

akikoueno@med.showa-u.ac.jp


Sponsor or person

Institute

Showa University Koto Toyosu Hospital

Institute

Department

Personal name



Funding Source

Organization

Showa University Koto Toyosu Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University Koto Toyosu Hospital

Address

5-1-38, Toyosu, Koto-ku, Tokyo, Japan

Tel

+81352046000

Email

th_irb@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学江東豊洲病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 08 Month 03 Day

Date of IRB

2017 Year 07 Month 28 Day

Anticipated trial start date

2017 Year 08 Month 10 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 08 Month 08 Day

Last modified on

2020 Year 08 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032686